The US Treasury Department has released proposed rules to implement the COINS Act, outlining plans to widen US outbound investment restrictions in sensitive technology sectors tied to certain "countries of concern." The current framework mainly targets entities linked to China, but the new proposal would tighten controls beyond that baseline and extend the regulatory scope to additional sensitive technologies and a broader set of countries.
In artificial intelligence, some investments that are still allowed under the current regime after a filing requirement would be reclassified as prohibited transactions under the proposal. Semiconductor restrictions would also be tightened, with high-bandwidth memory, photonic chips, and radiation-hardened chips listed among the areas facing stricter limits. At the same time, biotechnology would be added as a key regulated sector, covering areas such as brain-computer interfaces and automated laboratory software.
The proposal signals a broader push by the Treasury to expand the reach of outbound investment screening under the COINS Act framework.
According to ChainCatcher, the US Treasury Department has issued proposed rules to implement the COINS Act, with plans to broaden US outbound investment restrictions in sensitive technology sectors involving certain "countries of concern."
The current regime mainly covers entities linked to China. Under the proposal, restrictions on areas such as artificial intelligence and semiconductors would be tightened beyond the existing framework, while the regulatory scope would also be extended to more sensitive technologies and a wider range of countries.
Tighter proposed limits for AI and semiconductors
In AI, some investments that are still permitted under current rules after a filing requirement would be converted into prohibited transactions under the proposal. In semiconductors, high-bandwidth memory, photonic chips, and radiation-hardened chips would also fall under stricter restrictions.
Biotechnology added as a key regulated sector
At the same time, biotechnology has been added as a priority regulatory area, including brain-computer interfaces and automated laboratory software.
This article was originally published by Bit.Fan. For more cryptocurrency news and market insights, visit www.bit.fan. Disclaimer:
The market information, project data, and third-party content displayed on this platform are for industry information sharing only and do not constitute any form of investment advice or return commitment.
Cryptocurrency trading carries high risks. Users should fully assess their risk tolerance and make independent decisions. All profits, losses, and legal responsibilities are borne by the users themselves.
